Exact Sciences Announces First-Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Exact Sciences (EXAS) Misses Q1 EPS by 21c, Updates Guidance
May 1, 2025 4:24 PM EDTExact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.54), $0.21 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $707 million versus the consensus estimate of $688.78 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.07-3.12 billion, versus the consensus... More



